Sort
40,608 grants matching “prostate cancer”
Vaccine and immunotherapy strategies for cancer and viruses causing cancer
$596,948Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2025 · CA
Multilevel Resilience Trajectories in the Transition to Cancer Survivorship
$596,896Crystal L Park · University Of Connecticut Storrs · UH3 · FY2021 · CA
Metabolic Targets in Pten-Tumors
$596,888Jeffrey A Smith · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2010 · CA
De-implementation of low value castration for men with prostate cancer
$596,759Ted Albert Skolarus · University Of Michigan At Ann Arbor · R37 · FY2021 · CA
Genome-wide Copy Number Variation and Breast Cancer Risk
$596,660Jirong Long · Vanderbilt University · R01 · FY2011 · CA
DEVELOPING NOVEL THERAPEUTICS TARGETING UNDIFFERENTIATED AND CASTRATION-RESISTANT PROSTATE CANCER STEM CELLS
$596,639Health Research, Inc. · · FY2014 · Department of the Army
Image-guided ultrasound ablation for precision targeting of prostate cancer
$596,528Everette C Burdette · Acoustic Medsystems, Inc. · R01 · FY2022 · CA
Identifying causal variants and genes underlying breast cancer risk loci
$596,487Matthew L Freedman · Dana-Farber Cancer Inst · R01 · FY2020 · CA
Novel ctDNA biomarker for androgen therapy in metastatic prostate cancer
$596,475Christopher A Maher · Washington University · R01 · FY2024 · CA
Evaluating prostate cancer phenotype and genotype classification from circulating tumor DNA as biomarkers for predicting treatment outcomes
$596,466Gavin Ha · Fred Hutchinson Cancer Center · R01 · FY2023 · CA
Typing the Transcriptome in Cancer Using Splicing Array
$596,441University Of California San Diego · R33 · FY2005 · CA
Nutrition, Deregulation of Imprinted Genes
$596,413Cathrine Hoyo · Duke University · R01 · FY2010 · ES
Improving prostate cancer screening by integration of SNPs with blood biomarkers
$596,412Robert J. Klein · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · CA
Genomic profiling of single circulating tumor cells in the precision medicine of metastatic prostate cancer
$596,405Hushan Yang · Thomas Jefferson University · R01 · FY2022 · CA
Mechanisms of Early Stage Mammary Tumorigenesis
$596,348Terry Van Dyke · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Techniques for MRI-Guided Cryosurgery of Prostate Cancer
$596,263Stanford University · R01 · FY2005 · CA
THE ROLE OF EZH2 IN PTEN-DEFICIENT PROSTATE CANCER PATHOGENESIS AND THERAPY
$596,250Mayo Clinic · · FY2014 · Department of Defense
MRI Imaging and Genetic Signatures to Manage Prostate Cancer Overdiagnosis
$596,203Alan Pollack · University Of Miami School Of Medicine · R01 · FY2016 · CA
MOUSE CANCER MODELS BY REGULATED INACTIVATION OF TUMOR S
$596,102University Of Texas Hlth Sci Ctr San Ant · U01 · FY2000 · CA
Diet and Genetic Risks for Prostate Cancer
$596,004Fred Hutchinson Cancer Research Center · R01 · FY2004 · CA
NCI NCTN- Network Lead Academic Participating Site: USC
$596,003Heinz Josef Lenz · University Of Southern California · U10 · FY2017 · CA
Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion
$595,777Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways
$595,777Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Precision Prostate Cancer Screening with Genetically Adjusted Prostate-Specific Antigen Levels
$595,685John S Witte · Stanford University · R01 · FY2021 · CA
PROSTATE, LUNG, COLORECTAL AND OVARIAN (PLCO) CANCER SCREENING TRIAL - SCREEN
$595,669Saundra S Buys · · N01 · FY2007 · CA